Oral corticosteroids and fracture risk: Relationship to daily and cumulative doses

Revmatologiia

Volumn 39, Issue 12, 2000, Pages 1383-1389

  Van Staa, T P ^a,b   Leufkens, H G M ^a   Abenhaim, L ^c,d   Zhang, B ^a   Cooper, C ^e,f  

^a UTRECHT UNIVERSITY   (Netherlands)

^b PROCTER AND GAMBLE COMPANY   (United States)

^c MCGILL UNIVERSITY   (Canada)

^d MCGILL UNIVERSITY   (Canada)

^e UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^f SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

Epidemiology; Fracture; Glucocorticoids; Osteoporosis; Risk factors

Indexed keywords

CORTICOSTEROID; GLUCOCORTICOID; PREDNISOLONE;

ADULT; AGE; ARTICLE; BONE DISEASE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DATA BASE; DOSE RESPONSE; DRUG EFFECT; DRUG EXPOSURE; DRUG MEGADOSE; FEMALE; FRACTURE; GENDER; GENERAL PRACTITIONER; HIP FRACTURE; HUMAN; INFORMATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; OSTEOPOROSIS; PRIORITY JOURNAL; RISK; UNITED KINGDOM; VERTEBRA FRACTURE;

EID: 0034502338     PISSN: 13100505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Lukert B. Glucocorticoid-induced osteoporosis. In: Marcus R, Feldman D, Kelsey J, eds. Osteoporosis. San Diego: Academic Press, 1996:801-13.
2. Reid IR. Gluco-corticoid-induced osteoporosis and other forms of secondary osteoporosis. In: Meunier PJ, ed. Osteoporosis: diagnosis and management. London: Martin Dunitz, 1998:233-50.
3. Luengo M, Picado C, Del Rio L, Guañabens N, Montserrat JM, Setoain J. Vertebral fractures in steroid dependent asthma and involutional osteoporosis: a comparative study. Thorax 1991;46:803-6.
4. Cooper C, Coupland C, Mitchell M. Rheumatoid arthritis, corticosteroid therapy and hip fracture. Ann Rheum Dis 1995;54:49-52.
5. Lems WF, Jahangier ZN, Jacobs JWG, Bulsma JWJ. Vertebral fractures in patients with rheumatoid arthritis treated with corticosteroids. Clin Exp Rheumatol 1995; 13:293-7.
6. McDougall R, Sibley J, Haga M, Russell A. Outcome in patients with rheumatoid arthritis receiving prednisone compared to matched controls. J Rheumatol 1994;21: 1207-13.
7. Saag KG, Koehnke R, Caldwell JR, et al. Low dose long-term corticosteroid therapy in rheumatoid arthritis: An analysis of serious adverse events. Am J Med 1994; 96:115-23.
8. Michel BA, Bloch DA, Wolfe F, Fries JF. Fractures in rheumatoid arthritis: An evaluation of associated risk factors. J Rheumatol 1993;20:1666-9.
9. Laan RFJM, van Riel PLCM, van Erning LJTO, Lemmens JAM, Ruijs SHJ, van de Putte LBA. Vertebral osteoporosis in rheumatoid arthritis patients: Effect of low dose prednisone therapy. Br J Rheumatol 1992;31:91-6.
10. Butler RC, Davie MWJ, Worsfold M, Sharp CA. Bone mineral content in patients with rheumatoid arthritis: Relationship to low-dose steroid therapy. Br J Rheumatol 1991;30:86-90.
11. Michel BA, Bloch DA, Fries JF. Predictors of fractures in early rheumatoid arthritis. J Rheumatol 1991;18:804-9.
12. Sambrook PN, Eisman JA, Yeates MG, Pocock NA, Eberl S, Champion GD. Osteoporosis in rheumatoid arthritis: safety in low dose corticosteroids. Ann Rheum Dis 1986;45:950-3.
13. Verstraeten A, Dequeker J. Vertebral and peripheral bone mineral content and fracture incidence in postmenopausal patients with rheumatoid arthritis: effect of low dose corticosteroids. Ann Rheum Dis 1986;45:852-7.
14. Dykman TR, Gluck OS, Murphy WA, Hahn TJ, Hahn BH. Evaluation of factors associated with glucocorticoid-induced osteopenia in patients with rheumatic diseases. Arthritis Rheum 1985;28:361-8.
15. Hooyman JR, Melton JL IIII, Nelson AM, O'Fallon MW, Riggs BL. Fractures after rheumatoid arthritis. A population-based study. Arthritis Rheum 1984;27:1353-61.
16. Adinoff AD, Hollister MD, Roger J. Steroid-induced fractures and bone loss in patients with asthma. New Engl J Med 1983;309:265-8.
17. Saville PD, Oved K. Osteoporosis of rheumatoid arthritis: influence of age, sex and corticosteroids. Arthritis Rheum 1967;10:423-31.
18. McConkey B, Fraser GM, Bligh AS. Osteoporosis and purpura in rheumatoid disease: Prevalence and relation to treatment with corticosteroids. Q J Med, New Series XXXI 1962;124:419-27.
19. Van Staa TP, Leufkens B, Abenhaim L, Zhang B, Cooper C. Use of oral corticosteroids and risk of fractures. J Bone Miner Res 2000;15:993-1000.
20. Hall G. Pharmacoepidemiology using a UK Database of Primary Care Records. Pharmacoepidemiol Drug Safety 1992;1:33-7.
21. Lis Y, Mann RD. The Vamp Research Multi-purpose Database in the U.K. J Clin Epidemiol 1995;48:431-43.
22. Mann RD, Hall G, Chukwujindu J. Research implications of computerised primary care. Post Marketing Surveillance 1992;5:259-68.
23. Hollowell J. General Practice Research Database (GPRD): Scope and quality of data. London: Office of Population Censuses and Statistics, 1994.
24. Anonymous. The general practice research database: information for researchers. London: Office for National Statistics, 1996.
25. Walley T, Mantgani A. The UK General Practice Research Database. Lancet 1997;350:1097-9.
26. Jick H, Jick SS, Derby LE. Validation of Information recorded on general practitioner based computerised data resource in the United Kingdom. Br Med J 1991;302: 766-8.
27. Jick H, Terris BZ, Derby LE, Jick SS. Further validation of information recorded on a general practitioner based computerised data resource in the United Kingdom. Pharmacoepidemiol Drug Safety 1992;1:347-9.
28. Nazareth I, King M, Haines A, Rangel L, Myers S. Accuracy of diagnosis of psychosis on general practice computer system. Br Med J 1993;307:32-4.
29. Van Staa TP, Abenhaim L. The quality of information recorded on a UK database of primary care records: a study of hospitalization due to hypoglycemia and other conditions. Pharmacoepidemiol Drug Safety 1994;3:15-21.
30. British Medical Association and the Royal Pharmaceutical Society of Great Britain. British National Formulary Number 32 (September 1996). Wallingford, UK: Pharmaceutical Press, 1996.
31. Breslow NE, Day NE. Statistical methods in cancer research. Lyon: International Agency for Research on Cancer, 1987.
32. Greenland S. Dose-response and trend analysis in epidemiology: alternatives to categorical analysis. Epidemiology 1995;6:356-65.
33. Durrleman S, Simon R. Flexible regression models with cubic splines. Stat Med 1989;8:551-61.
34. Pizer M. Numerical Computing and Mathematical Analysis. Chicago: Science Research Associates, 1975. Chapter 4, pp. 251-456.
35. SAS/GRAPH Software: Reference, Version 6, First Edition, Vol. 1. Cary, NC: SAS Institute, 1996.
36. Dequeker J, Westhovens R. Low dose corticosteroid associated osteoporosis in rheumatoid arthritis and its prophylaxis and treatment: Bones of contention. J Rheumatol 1995;22:1013-9.
37. Spector TD, Sambrook PN. Steroid osteoporosis. Br Med J 1993;307:519-20.
38. Cooper C. Osteoporosis in rheumatological practice: questions to be answered. Ann Rheum Dis 1995;54:1-2.
39. Henderson NK, Sambrook PN. Relationship between osteoporosis and arthritis and effect of corticosteroids and other drugs on bone. Curr Opin Rheumatol 1996; 8:365-9.
40. Eastell R, Reid DM, Compston J, et al. A UK consensus group on management of glucocorticoid induced osteoporosis: an update. J Intern Med 1998;244:271-92.
41. van Staa TP, Abenheim L, Cooper C, Zhang B, Leufkens HGM. The use of a large pharmacoepidemiological database to study exposure to oral corticosteroids and risk of fractures: validation of study population and results. Pharmacoepidemiol Drug Safety 2001; in press.
42. Cooper C, O'Neill T, Silman A. The epidemiology of vertebral fractures. Bone 1993;14:S89-97.